PARP1 and cutaneous melanoma: To confirm the obtained results, we performed the immunohistochemical evaluation of PARP1 protein expression in tumor cells of 128 skin melanoma patients, followed by an analysis of the correlation between PARP1 expression and detailed clinical and histopathological parameters, as well as patient survival.